Navigation Links
N. California Researchers Testing Whether Marijuana Chemical Can Slow Cancer Growth, With Funding by Susan G. Komen for the Cure(R)
Date:4/9/2009

Largest Breast Cancer Organization Investing $60 Million to Research Despite Down Economy

SAN FRANCISCO, April 9 /PRNewswire-USNewswire/ -- Testing whether a powerful ingredient in marijuana can help slow the growth of aggressive breast cancer cells is just one of six Bay Area breast cancer studies being funded this year by Susan G. Komen for the Cure(R), the global leader in the breast cancer movement announced today.

The projects are part of a $60 million portfolio of 2009 research grants that Komen for the Cure is investing with scientists worldwide to find the cures for breast cancer.

"Breast cancer doesn't care about the economy, and with more than 1.3 million new cases of breast cancer expected this year, the need for new research is more urgent than ever," said Hala Moddelmog, Komen's CEO and president.

In the Bay Area this year, Komen's $1.8 million in grants will go to the University of California at San Francisco, Stanford University School of Medicine and California Pacific Medical Center.

The UCSF study will try to improve bilingual communication and education between Latinas and their health care providers. One Stanford grant, if successful, could reverse some of the debilitating neurological and cognitive side effects of brain metastases, halt the progression of disease and possibly reduce mortality. And CPMC researchers will test whether cannabidiol - an ingredient in marijuana - can inhibit the aggressive growth of some breast cancers.

"Komen's infusion of millions of dollars into research projects means that promising research that is designed to treat and ultimately eradicate breast cancer will continue," said Eric Winer, M.D., Komen's chief scientific advisor.

During the past 27 years, Komen has invested $400 million to fund research globally, starting with Komen's first grant in 1982 for $28,000. A decade later, the annual total had grown to 21 grants worth $590,000 and 10 years after that, Komen distributed $21 million in research funds. This year, Komen is providing researchers worldwide with $60 million. In the last three years alone, Komen has invested nearly $237 million for breast cancer research.

In 2008, Komen created Promise Grants - a new category of multi-year, multi-million dollar grants designed to discover and deliver cures for breast cancer more quickly.

Here is a list of local institutions, the researchers and the projects Komen is funding this year, pending agreements:

University of California at San Francisco

*Celia Kaplan, $450,185, Breast Cancer Risk Reduction in Primary Care Clinics: A Bilingual Intervention for Women and Physicians

Stanford University School of Medicine

*Irene Wapnir, $600,000, From Bench to Bedside: Treatment of Breast Cancer Brain Metastasis with 131I and Radiosensitizers

*Roeland Nusse, $180,000, 'Wnt signaling in human breast cancer stem cells.

*Michael Clarke, $180,000, Functions of microRNAs in metastatic tumor initiating cells of human breast cancer

*Howard Chang, $180,000, Noncoding RNA, Polycomb and Breast Cancer Progression

California Pacific Medical Center

*Sean McAlister, $593,713, Inhibition of Breast Cancer Cell Aggressiveness by Cannabidiol

About Susan G. Komen for the Cure(R)

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure(R), we have invested more than $1.3 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit www.komen.org or call 1-877 GO KOMEN.


'/>"/>
SOURCE Susan G. Komen for the Cure
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Uncovering the Secrets of Getting California Health Insurance to Pay for Autism Treatments
2. California Health Plans Vital to States Economy
3. Statement by Bruce Bodaken Chairman & CEO, Blue Shield of California
4. Health and Wellness Partners, Inc., a Wholly Owned Subsidiary of Zealous Inc., is Awarded the Exclusive California Distribution Rights for RockHard Weekend!!!
5. California Association of Health Underwriters Calls Foul Over Partisan Health Care Reform Process
6. California Moms to Lawmakers: Health Care Coverage is a Lifesaver for California Families
7. California Association of Health Plans Recognizes World Autism Awareness Day by Highlighting Medical Services Plans Provide
8. Mobile Dog Heart Health Tour Through California Cities to Provide Free Heart Examinations in Sound-Proof Setting
9. Sutter Health Ranks Tops in California for Quality Health Care
10. Barry Arbuckle, Ph.D., President & CEO of MemorialCare Medical Centers to Chair Southern California March for Babies 2009, March of Dimes Largest Fundraising Events
11. California Medical Association Names EMPLOYERS(R) Provider of Choice for its 35,000 Physician Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics ... PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... of Morris F. Collen, a pioneer in the field of medical informatics, this prestigious ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
Breaking Medicine Technology: